ICU Medical (ICUI) to Release Earnings on Thursday

ICU Medical (NASDAQ:ICUI) will likely be issuing its Q1 2025 quarterly earnings data after the market closes on Thursday, May 8th. Analysts expect the company to announce earnings of $1.23 per share and revenue of $574.15 million for the quarter.

ICU Medical Stock Performance

Shares of NASDAQ ICUI opened at $136.59 on Thursday. The stock has a market cap of $3.36 billion, a PE ratio of -29.89 and a beta of 0.86. ICU Medical has a 1 year low of $96.97 and a 1 year high of $196.26. The firm has a fifty day moving average price of $142.32 and a 200-day moving average price of $157.35. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

Wall Street Analyst Weigh In

ICUI has been the topic of several research analyst reports. StockNews.com downgraded ICU Medical from a “buy” rating to a “hold” rating in a research report on Thursday, April 24th. Raymond James set a $97.00 price target on ICU Medical in a research note on Wednesday, March 12th. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research note on Tuesday, April 8th. Finally, KeyCorp reduced their target price on ICU Medical from $209.00 to $191.00 and set an “overweight” rating on the stock in a report on Monday, April 21st. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $162.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.